Dusseldorf - Delayed Quote EUR

Abbott Laboratories (ABL.DU)

115.98

+0.52

+(0.45%)

At close: April 17 at 7:31:30 PM GMT+2

Nvidia, AMD see charges due to new China export rules: Morning Buzz

The major averages were broadly lower near noon, with the Nasdaq down over 300 points amid escalating trade tensions and new export restrictions. This follows the U.S. government’s decision to tighten export controls on advanced AI-related computer chips. The recent U.S. actions have intensified concerns over a potential trade war. President Donald Trump has announced a new investigation into critical mineral imports and imposed steep tariffs on Chinese imports. In retaliation, China has incre

TipRanks 12 hours ago

AMD

GOOG

IAG
Abbott price target raised to $140 from $138 at Evercore ISI

Evercore ISI raised the firm’s price target on Abbott (ABT) to $140 from $138 and keeps an Outperform rating on the shares after the company reported organic growth of 6.9% in Q1 and the strength was “broad based” along with an overall EPS beat as earnings grew about 11%. In an environment where uncertainty is the dominating theme, the ability to protect the bottom-line should be appreciated, says the analyst, who calls Abbott “the perfect stock to weather macro uncertainty.” Published first on

TipRanks 12 hours ago

ABT
Company News for Apr 17, 2025

Companies In The News Article Are:AMD,ABT, PGR, TRV

Zacks 14 hours ago

AMD

PGR

ABT
Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023. In 2023, the healthcare industry made up 17.6% of the US economy, an increase of 17.4% from 2022. The growth of Medicare and private […]

Insider Monkey 15 hours ago

ABT
Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices ...

Abbott Laboratories (ABT) reports robust earnings with a 12.5% increase in medical devices sales and a 7% rise in nutrition, despite a decline in diagnostics due to reduced COVID-19 testing.

GuruFocus.com 21 hours ago

ABT
Q1 2025 Abbott Laboratories Earnings Call

Q1 2025 Abbott Laboratories Earnings Call

Thomson Reuters StreetEvents 23 hours ago

ABT
Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs

Barclays outlines which MedTech stocks could feel the most pressure from Trump's anticipated global pharmaceutical tariffs

GuruFocus.com yesterday

BCS

MDT

ABT
Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers

Josh Lipton, joined by Defiance ETFs CEO and chief investment officer Sylvia Jablonski, examines some of the trading day's trending tickers. Hertz (HTZ) shares pop after Bill Ackman-led Pershing Square Capital Management disclosed a stake of 12.7 million shares of the rental car company's stock. Abbott Laboratories (ABT) gained after the medical tech company reported stronger-than-expected earnings. Interactive Brokers (IBKR) tumbles after earnings results missed analyst estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video yesterday

HTZ

HTZWW

IBKR
Abbott Makes A Bullish Move, Shrugging Off Covid Test Malaise

Abbott stock jumped Wednesday despite a mixed first-quarter report thanks to light sales of its Covid tests.

Investor's Business Daily yesterday

ABT
Is Abbott Laboratories (ABT) the Best Dividend Monarch to Invest in Now?

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware […]

Insider Monkey yesterday

ABT

^GSPC
Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities

Abbott Laboratories shares surged Wednesday after the medical device maker said it plans to invest $500 million in U.S. operations and topped Wall Street’s expectations with its first-quarter results.

Investopedia yesterday

ABT
Abbott Laboratories (NYSE:ABT) Reports Q1 Sales And Income Growth With Earnings At US$0.76

Abbott Laboratories (NYSE:ABT) recently reported positive Q1 2025 results, showing increased sales and net income, which may have bolstered its share price by 14% last quarter. The enhanced financial performance, including a rise in diluted EPS, highlighted profitability improvements. This, coupled with ongoing stock buybacks and a longstanding commitment to dividends, likely contributed to investor confidence. Despite broader market concerns such as U.S.-China trade tensions impacting tech...

Simply Wall St. yesterday

ABT
Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market

ABT delivers a strong underlying base business performance for the first quarter of 2025.

Zacks yesterday

ABT
Abbott Labs Bracing for Tariffs as Profits Rise

Abbott Labs boosted its earnings in the first quarter and hinted that its full-year guidance might have gotten a lift were it not for looming cost hikes from the recent tariff war.

The Wall Street Journal yesterday

ABT
United Airlines & Abbott Labs earnings, Ackman's Hertz stake

Brad Smith outlines some of the top stories on Wall Street in just 60 seconds on today's Market Minute. United Airlines (UAL) shares rise after reporting earnings results and providing investors with dual outlooks depending on the health of the US economy. Abbott Laboratories (ABT) stock rises after the medical supply company reported better-than-expected earnings results. Hertz (HTZ) shares surge after Bill Ackman-led Pershing Square Capital Management disclosed a large stake in the rental car company. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video yesterday

HTZ

HTZWW

UAL
Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) jumped 5.4% in the morning session after the company reported decent first-quarter 2025 results with revenue in line, although its organic revenue fell slightly short of Wall Street's estimates. EPS in the quarter beat slightly, while full-year EPS guidance met expectations. The full-year sales outlook was also maintained, which was encouraging despite the uncertain macro backdrop.

StockStory yesterday

ABT
Top Midday Stories: Nvidia, AMD Flag Looming Charges Tied to China Export Licenses; ASML Shares Fall on Sales Miss, Downbeat Guidance

All three major US stock indexes were in the red at midday Wednesday, with the Nasdaq Composite down

PREMIUM
MT Newswires yesterday

NVDA

AMD

ABT
Abbott Labs Forecasts Tariff Impact of a ‘Few Hundred Million Dollars’

Abbott Laboratories forecasts an impact of "a few hundred million dollars" this year from Trump administration tariffs, Chief Executive Robert Ford told analysts Wednesday. The healthcare company sees the costs starting in the third quarter. Ford told analysts it is too early to simply double the 2025 estimate for how tariffs might affect Abbott in future years, but the company can cover them in the near term.

The Wall Street Journal yesterday

ABT
Pre-Markets Open in The Red

Pre-Markets Open in The Red

Zacks yesterday

ABT

ALV
Abbott Laboratories stock pops on earnings beat

Abbott Laboratories (ABT) stock is gaining after the healthcare tech company reported a first quarter earnings beat. Yahoo Finance Senior Healthcare Reporter Anjalee Khemlani sits down with Madison Mills and Brad Smith on Morning Brief to discuss the earnings print and the latest developments in the healthcare sector. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

Yahoo Finance Video yesterday

ABT

Performance Overview

Return	ABL.DU	S&P 500 (^GSPC)
YTD	+7.27%	-10.18%
1-Year	+19.05%	+5.19%
3-Year	+12.97%	+20.26%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Abbott Laboratories (ABL.DU)

Nvidia, AMD see charges due to new China export rules: Morning Buzz

Abbott price target raised to $140 from $138 at Evercore ISI

Company News for Apr 17, 2025

Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025

Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices ...

Q1 2025 Abbott Laboratories Earnings Call

Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs

Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers

Abbott Makes A Bullish Move, Shrugging Off Covid Test Malaise

Is Abbott Laboratories (ABT) the Best Dividend Monarch to Invest in Now?

Abbott Labs Stock Jumps on Strong Earnings, With $500M Investment in US Facilities

Abbott Laboratories (NYSE:ABT) Reports Q1 Sales And Income Growth With Earnings At US$0.76

Abbott Q1 Earnings Beat, Sales Miss, Stock Falls in Pre-Market

Abbott Labs Bracing for Tariffs as Profits Rise

United Airlines & Abbott Labs earnings, Ackman's Hertz stake

Abbott Laboratories (ABT) Shares Skyrocket, What You Need To Know

Top Midday Stories: Nvidia, AMD Flag Looming Charges Tied to China Export Licenses; ASML Shares Fall on Sales Miss, Downbeat Guidance

Abbott Labs Forecasts Tariff Impact of a ‘Few Hundred Million Dollars’

Pre-Markets Open in The Red

Abbott Laboratories stock pops on earnings beat

Performance Overview